Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 06, 2021

SELL
$51.39 - $66.9 $26,054 - $33,918
-507 Closed
0 $0
Q1 2021

Apr 14, 2021

SELL
$49.14 - $59.89 $39,066 - $47,612
-795 Reduced 61.06%
507 $30,000
Q4 2019

Feb 12, 2020

SELL
$19.57 - $28.96 $19,570 - $28,960
-1,000 Reduced 43.44%
1,302 $36,000
Q2 2019

Jul 15, 2019

BUY
$18.54 - $40.97 $24,139 - $53,342
1,302 Added 130.2%
2,302 $94,000
Q1 2019

May 14, 2019

BUY
$13.32 - $24.35 $13,320 - $24,350
1,000 New
1,000 $24,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.